Dopamine or PGE2 secretion in the tumor microenvironment also engages dopamine receptor D1 or EP4 receptor, respectively, to activate cAMP/CREB pathway and promote HCC progression [165, 166]. Here, CREB1 is linked to hepatocellular carcinoma.